KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Accumulated Expenses (2018 - 2025)

Historic Accumulated Expenses for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $23.4 million.

  • Twist Bioscience's Accumulated Expenses rose 764.88% to $23.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.4 million, marking a year-over-year increase of 764.88%. This contributed to the annual value of $31.3 million for FY2025, which is 701.93% down from last year.
  • Latest data reveals that Twist Bioscience reported Accumulated Expenses of $23.4 million as of Q4 2025, which was up 764.88% from $31.3 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Accumulated Expenses ranged from a high of $33.6 million in Q3 2024 and a low of $14.9 million during Q1 2021
  • For the 5-year period, Twist Bioscience's Accumulated Expenses averaged around $24.7 million, with its median value being $24.6 million (2023).
  • In the last 5 years, Twist Bioscience's Accumulated Expenses surged by 7280.05% in 2021 and then plummeted by 1069.73% in 2023.
  • Over the past 5 years, Twist Bioscience's Accumulated Expenses (Quarter) stood at $18.7 million in 2021, then rose by 24.24% to $23.3 million in 2022, then decreased by 10.7% to $20.8 million in 2023, then increased by 4.59% to $21.7 million in 2024, then grew by 7.65% to $23.4 million in 2025.
  • Its last three reported values are $23.4 million in Q4 2025, $31.3 million for Q3 2025, and $29.0 million during Q2 2025.